CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 11th Annual JMP Securities Research Conference on Tuesday, May 15 at 2:30 p.m. PT at the Ritz-Carlton in San Francisco.
